The Absence of Synergism between the Effects of an Aldose Reductase Inhibitor, Epalrestat, and a Vasodilator, Cilostazol, on the Nerve Conduction Slowing and the Myelinated Fiber Atrophy in Streptozotocin-Induced Diabetic Rats

By Sasaki H.   Naka K.   Kishi Y.   Furuta M.   Sanke T.   Mukoyama M.   Nanjo K.  

Experimental Neurology, Vol. 146, Iss. 2, 1997-08 ,pp. : 466-470

Elsevier

Access to resources Recommend Favorite

Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor

By Yagihashi Soroku  

Brain, Vol. 124, Iss. 12, 2001-12 ,pp. : 2448-2458

Oxford University Press

Access to resources Recommend Favorite

Therapeutic Effects of Aldose Reductase Inhibitor on Experimental Diabetic Neuropathy through Synthesis/Secretion of Nerve Growth Factor

By Ohi T.   Saita K.   Furukawa S.   Ohta M.   Hayashi K.   Matsukura S.  

Experimental Neurology, Vol. 151, Iss. 2, 1998-06 ,pp. : 215-220

Elsevier

Access to resources Recommend Favorite

Electrophysiological assessment of diabetic polyneuropathy: comparison among motor, sensory and microneurographical conduction studies

By Hasegawa O.   Komiyama A.   Kurita R.   Nara Y.   Matsumoto S.   Matsumoto M.   Iino M.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 219-219

Elsevier

Access to resources Recommend Favorite

An electrophysiological and clinical evaluation of dysphagia in neuromuscular disorders

By Yuceyar N.   Aydogdu I.   Ertas M.   Ertekin C.  

Electroencephalography and Clinical Neurophysiology, Vol. 99, Iss. 4, 1996-10 ,pp. : 310-310

Elsevier

Access to resources Recommend Favorite